Top-News
Biotechnologie USA

Gossamer Bio Inc Aktie

Aktie
WKN:  A2PCBS ISIN:  US38341P1021 US-Symbol:  GOSS
0,971 €
+0,02 €
+2,10%
03.01.25
Handeln Depot/Watchlist
Aktienanzahl *
226,22 Mio.
Marktkapitalisierung *
150,69 Mio. €
Streubesitz
18,44%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 09.07.2024

Gossamer Bio Inc News

19.12.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PR Newswire
13.12.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PR Newswire
06.12.22 - PR Newswire
Thinking about buying stock in Summit Therapeutics, Gossamer Bio, Xpeng, BioNano Genomics, or Canopy Growth Corp?
Thinking about buying stock in Summit Therapeutics, Gossamer Bio, Xpeng, BioNano Genomics, or Canopy Growth Corp? PR Newswire
27.05.20 - PR Newswire
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute ...
20.05.20 - PR Newswire
GOSSAMER DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Gossamer Bio, Inc. To Contact The Firm
GOSSAMER DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Gossamer Bio, Inc. To Contact The Firm PR ...
12.04.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PR Newswire
12.04.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PR Newswire
07.04.20 - PR Newswire
Gossamer (GOSS) Class Action Alert: Johnson Fistel Encourages Investors to Contact Firm
Gossamer (GOSS) Class Action Alert: Johnson Fistel Encourages Investors to Contact Firm PR Newswire
06.04.20 - PR Newswire
GOSS INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies Gossamer Bio, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm
GOSS INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies Gossamer Bio, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm PR ...

Newssuche

Videos

newspaper
05.01.25
Strategien mit 500-2000% Performance
Gerade als Trader mit begrenzter Kapitaldecke benötigt man Strategien, die relativ wenig Kapital binden ... Mehr »